Inventor · disambiguated record
Rutul Shah
Also filed as: SHAH RUTUL · SHAH RUTUL R
13 granted patents·9 pending applications·16 citations·filing 2016–2024
88Inventor score
Top patents by PatentIndex Score
22 records- 0189US11118168B2Expression of novel cell tagsPRECIGEN INC·Filed 2018·Granted Sep 14, 2021·4 cites·5 claims
- 0288US11771718B2Polypeptide compositions comprising spacersINTREXON CORP·Filed 2018·Granted Oct 3, 2023·3 cites·34 claims
- 0388US11319380B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2019·Granted May 3, 2022·3 cites·11 claims
- 0486US11692194B2Modulating expression of polypeptides via new gene switch expression systemsPRECIGEN INC·Filed 2018·Granted Jul 4, 2023·2 cites·32 claims
- 0585US12060585B2Expression of novel cell tagsPRECIGEN INC·Filed 2021·Granted Aug 13, 2024·1 cites·15 claims
- 0683US11946054B2Modulating expression of polypeptides via new gene switch expression systemsPRECIGEN INC·Filed 2020·Granted Apr 2, 2024·1 cites·30 claims
- 0781US2025304930A1Expression of novel cell tagsPRECIGEN INC·Filed 2024·Application pending·0 cites
- 0880US2024368305A1Muc16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2024·Application pending·0 cites
- 0978US2024263183A1Modulating expression of polypeptides via new gene switch expression systemsPRECIGEN INC·Filed 2024·Application pending·0 cites
- 1076US11787848B2CD33 specific chimeric antigen receptorsPRECIGEN INC·Filed 2017·Granted Oct 17, 2023·1 cites·45 claims
- 1176US11535669B2Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2019·Granted Dec 27, 2022·1 cites·15 claims
- 1275US11981746B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2022·Granted May 14, 2024·0 cites·81 claims
- 1375US11976134B2MUC16 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2022·Granted May 7, 2024·0 cites·70 claims
- 1474US2025325665A1Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2024·Application pending·0 cites
- 1573US2023414661A1Polypeptide compositions comprising spacersPRECIGEN INC·Filed 2023·Application pending·0 cites
- 1671US12180517B2Expression of novel cell tagsPRECIGEN INC·Filed 2021·Granted Dec 31, 2024·0 cites·32 claims
- 1768US12194094B2Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2021·Granted Jan 14, 2025·0 cites·15 claims
- 1866US2024141045A1Fusion constructs and methods of using thereofPRECIGEN INC·Filed 2022·Application pending·0 cites
- 1965US2025388905A1POLYCISTRONIC miRNA CONSTRUCTS FOR IMMUNE CHECKPOINT INHIBITIONPRECIGEN INC·Filed 2023·Application pending·0 cites
- 2062US12275772B2ROR-1 specific chimeric antigen receptors and uses thereofPRECIGEN INC·Filed 2021·Granted Apr 15, 2025·0 cites·58 claims
- 2155US2022220187A1Chimeric receptor therapyPRECIGEN INC·Filed 2022·Application pending·0 cites
- 2237US2019062394A1Improved Therapeutic Control of Proteolytically Sensitive, Destabilized Forms of Interleukin-12INTREXON CORP·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rutul Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →